#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crigler-Najjar syndrome Neuropathic arthropathy Soft tissue necrosis Cystic fibrosis lung Cystic fibrosis Cutaneous T-cell lymphoma stage I Phenylketonuria Indolent systemic mastocytosis Malignant glioma Endocrine ophthalmopathy Niemann-Pick disease Marginal zone lymphoma recurrent Neurodevelopmental disorder Gastrointestinal neuroendocrine tumour Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Osteosarcoma – Trials in Disease Prolymphocytic leukaemia – Diagnostics Anaplastic thyroid cancer Ornithine transcarbamoylase deficiency – Treatment Wolfram syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma – Treatment Noonan syndrome – Treatment Anaplastic thyroid cancer – Diagnostics Aicardi-Goutieres syndrome – Life with Disease Haemophagocytic lymphohistiocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Df1001 Insulin Human (Rdna) GSKVX000000030810 Netupitant Moxifloxacin Hydrochloride ALPROSTADIL Enfortumab Vedotin CITRIC ACID ANHYDROUS Salbutamol Sulfate Ph. Eur. Ketotifen Hydrogen Fumarate BUMETANIDE Mercaptopurine Autologous Pancreatic Islets Oseltamivir Sodium Nitroprusside Dihydrate Agomelatine Octreotide Vinorelbine Telitacicept Gentamicin Sulfate More therapies…

    Learn about Your Condition

    Glucose tolerance impaired Hypotransferrinaemia Metastases to meninges Diffuse large B-cell lymphoma Cortisol abnormal Anaemia of pregnancy Depression Brain injury Abdominal wall pain Dedifferentiated liposarcoma Oral lichen planus Invasive breast carcinoma Yellow fever Peritoneal neoplasm Gaucher's disease type III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic candida

  • Study on Rezafungin Levels in Critically Ill Patients with Invasive Candidiasis Undergoing ECMO or RRT

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Candida infection
    • Systemic candida
    Investigated Drugs:
    • Rezafungin Acetate
    Austria

  • Study on the Effectiveness and Safety of Fosmanogepix Compared to Caspofungin and Fluconazole for Adults with Candidemia or Invasive Candidiasis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Caspofungin
    • Fluconazole
    • FOSMANOGEPIX
    Austria Belgium Bulgaria France Germany Greece +2

  • Shortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Sodium Lactate
    • Caspofungin Acetate
    • Saline
    Germany

  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Caspofungin
    • Anidulafungin
    • Fluconazole
    France

  • Study of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Recombinant Human Interferon Gamma 1B
    Germany Greece The Netherlands Romania

  • Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Clotrimazole
    • Ibrexafungerp
    • Anidulafungin
    Belgium Bulgaria France Germany Greece Italy +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!